Stelara (Ustekinumab) 130 mg/26 mL Injection – Advanced Biologic Therapy for Inflammatory Conditions

Stelara (Ustekinumab) 130 mg/26 mL is a targeted biologic injection designed to inhibit interleukin-12 and interleukin-23, providing profound clinical relief for patients managing moderate-to-severe Crohn's disease and ulcerative colitis.